FDA Brief

Company record

ACCORD BIOPHARMA INC

0 FDA warning letters since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about ACCORD BIOPHARMA INC.

Recalls

ReportedClassFirmProduct and reason
Jul 8 Class II ACCORD BIOPHARMA INC
Drug
IMULDOSA, (ustekinumab-srlf) Injection, 130 mg/26 mL (5mg/mL), Rx only, Single dose vial, Manufactured by Accord BioPharma Inc., 8041 Arco corporate Drive, Suite 200, Raleigh, NC 27617, USA, Manufactured at: Catalent Ind…
Lack of assurance of Sterility: